Juvederm Volift Lidocaine (2x1ml)

JUVEDERM® VOLIFT™ LIDOCAINE

Juvéderm® VOLIFT™ is an advanced, cohesive, 3D hyaluronic acid matrix dermal filler, manufactured by Allergan.

It differs from the ULTRA product in that it is a much thicker hyaluronic acid gel, which has been produced by modifying the cross-linking technique by using low molecular weight hyaluronic acid in order to create a more viscous result, which can then be used for recontouring and restoring the face in the case of age-releated volume loss..

Juvéderm® VOLIFT™ contains non-animal hyaluronic acid in a highly viscous gel with the addition of 0,3% lidocaine, local anaesthetic to provide more comfort both during and after injection.

Hyaluronic acid is completely broken down within the skin over a period of months, eventually leaving no trace of the filler. According to the manufacturer Juvéderm® VOLBELLA™ has enhanced stability and resistance to degradation by heat and the body’s metabolism, providing a duration of the product up to 18 months.

What makes this filler unique is its patented Vycross technology which, through more efficient cross linking, produces greater lift capacity and longer lasting results.

Juvederm® VOLIFT™ with Lidocaine the latest addition to the Juvéderm range of hyaluronic acid (HA) dermal fillers produced using the unique VYCROSS™ technology. This provides a versatile treatment option for patients who are looking for a discreet, natural look with minimal swelling and long-lasting result. JUVEDERM® VOLIFT™ is designed to smooth deep wrinkles for a refreshed look, as well as gently restoring natural-looking contours in the lower face.. 

INDICATIONS

• loss of volume or definition,
• appearance of 'static' wrinkles such as deeper nasolabial folds,
• face contouring and volume restoration,
• natural-looking lip volume,
• Marionette Lines.

COMPOSITION

Hyaluronic Acid: 17,5 mg/ml

Lidocaine: 0,3%

PACKAGE

2 x 1 ml prefilled syringe

needles: 4 x 30G 1/2

CONTRAINDICATED

• hypersensitivity to one of the components,
• skin infection near the site of injection,
• patients susceptible to keloid formation,
• pregnant or lactating women,
• allergy or anaphylaxis,
• bleeding disorders,
• autoimmune disorders,
• antibiotic therapy.

Read the package leaflet before use.